ArticleOncotarget2017
Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.
Na Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it
ArticleOncotarget2017
Na Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.